APTERNA LIMITED
- Legal registered address
- 3rd Floor The Coade 98 Vauxhall Walk London United Kingdom SE11 5EL Copied!
Latest financial results as of 1 October 2025- Cash in bank
- £26.15k
- Current assets
- £57.25k
- Current creditors
- £49.11k
- Shareholders funds
- £2.33m
View full financial accounts- Cash in bank
- £26.15k
- Current assets
- £57.25k
- Current creditors
- £49.11k
- Shareholders funds
- £2.33m
- Company number
- 07583272 Copied!
Accounts
Latest annual accounts were to 31 March 2024
Next annual accounts are due by 31 December 2025
Company financial year end is on 31 March 2026
Confirmation statement
Latest confirmation statement statement dated 29 March 2025
Next statement due by 12 April 2026
Nature of business (SIC)
72110 - Research and experimental development on biotechnology
Previous company names
| Name | Date previous name changed |
|---|---|
| HCC RNA THERAPEUTICS LIMITED | 20 August 2013 |
Latest company documents
| Date | Description |
|---|---|
| 16/09/2516 September 2025 New | Director's details changed for Dr Declan Doogan on 2025-09-15 |
| 16/09/2516 September 2025 New | Registered office address changed from 1 Vincent Square London SW1P 2PN to 3rd Floor the Coade 98 Vauxhall Walk London SE11 5EL on 2025-09-16 |
| 16/09/2516 September 2025 New | Director's details changed for Robert Sebastian Habib on 2025-09-15 |
| 31/03/2531 March 2025 | Confirmation statement made on 2025-03-29 with updates |
| 20/12/2420 December 2024 | Accounts for a small company made up to 2024-03-31 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company